Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Current Leases (2023 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Current Leases for 3 consecutive years, with $322000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases rose 109.09% to $322000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $322000.0 through Dec 2025, up 109.09% year-over-year, with the annual reading at $322000.0 for FY2025, 109.09% up from the prior year.
  • Current Leases hit $322000.0 in Q4 2025 for Connect Biopharma Holdings, down from $336000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $900000.0 in Q1 2025 to a low of $154000.0 in Q4 2024.
  • Historically, Current Leases has averaged $391166.7 across 3 years, with a median of $329000.0 in 2025.
  • Biggest five-year swings in Current Leases: tumbled 45.96% in 2024 and later soared 109.09% in 2025.
  • Year by year, Current Leases stood at $285000.0 in 2023, then crashed by 45.96% to $154000.0 in 2024, then skyrocketed by 109.09% to $322000.0 in 2025.
  • Business Quant data shows Current Leases for CNTB at $322000.0 in Q4 2025, $336000.0 in Q3 2025, and $350000.0 in Q2 2025.